Prescient Therapeutics Limited’s (PTX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Prescient Therapeutics Limited is a Sell.

Prescient Therapeutics Limited’s (PTX) 20-Day exponential moving average is 0.05, while Prescient Therapeutics Limited’s (PTX) share price is <AU$0.1, making it a Buy.

Prescient Therapeutics Limited’s (PTX) 50-Day exponential moving average is 0.05, while Prescient Therapeutics Limited’s (PTX) share price is <AU$0.1, making it a Buy.

Prescient Therapeutics Limited (PTX) Pivot Points

Apr 28, 2024, 04:01 AM

Classic

0.05

0.06

Fibonacci

0.05

0.06

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prescient Therapeutics Limited (PTX) Moving Averages

Apr 28, 2024, 04:01 AM

MA5

0.05Buy

MA10

0.05Buy

MA20

0.05Buy

MA50

0.05Buy

MA100

0.06Sell

MA200

0.07Sell

Prescient Therapeutics Limited’s (PTX) 10-Day exponential moving average is 0.05, while Prescient Therapeutics Limited’s (PTX) share price is <AU$0.1, making it a Buy.

Prescient Therapeutics Limited’s (PTX) 100-Day exponential moving average is 0.06, while Prescient Therapeutics Limited’s (PTX) share price is <AU$0.1, making it a Sell.

Prescient Therapeutics Limited’s (PTX) stock price is <AU$0.1 and Prescient Therapeutics Limited’s (PTX) 50-day simple moving average is 0.05, creating a Buy signal.

Prescient Therapeutics Limited’s (PTX) stock price is <AU$0.1 and Prescient Therapeutics Limited’s (PTX) 100-day simple moving average is 0.06, creating a Sell signal.

Prescient Therapeutics Limited’s (PTX) stock price is <AU$0.1 and Prescient Therapeutics Limited’s (PTX) 200-day simple moving average is 0.07, creating a Sell signal.

Prescient Therapeutics Limited (PTX) Technical Indicators

Apr 28, 2024, 04:01 AM

RSI (14)

60.05

Neutral

STOCH (9,6)

88.55

Sell

STOCHRSI (14)

88.55

Sell

MACD (12,26)

<0.01

Sell

ADX (14)

27.60

Neutral

Williams %R

-13.33

Sell

CCI (14)

134.09

Sell

ATR (14)

<0.01

Ultimate Oscillator

49.23

Neutral

ROC

14.00

Buy

Prescient Therapeutics Limited’s (PTX) Relative Strength Index (RSI) is 60.05, creating a Neutral signal.

Prescient Therapeutics Limited’s (PTX) Trend Strength Indicator (ADX) is 27.60, creating a Neutral signal.

Prescient Therapeutics Limited’s (PTX) Commodity Channel Index (CCI) is 134.09, creating a Sell signal.

Prescient Therapeutics Limited’s (PTX) Price Rate of Change (ROC) is 14.00, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is PTX a Buy, Hold, or Sell?

Based on PTX’s technical indicators, PTX is a Hold.

What is PTX’s RSI (14)?

PTX’s RSI (14) is 60.05, which suggests PTX is a Neutral.

What is PTX’s MACD?

PTX’s MACD is <0.01, which suggests PTX is a Sell.

What is PTX’s 5-day moving average?

PTX’s 5-day moving average is 0.05, which suggests PTX is a Buy.

What is PTX’s 20-day moving average?

PTX 20-day moving average is 0.05, which suggests PTX is a Buy.

What is PTX’s 50-day moving average?

PTX’s 50-day moving average is 0.05, which suggests PTX is a Buy.

What is PTX’s 200-day moving average?

PTX’s 200-day moving average is 0.07, which suggests PTX is a Sell.

What is PTX’s Williams % R (14)?

PTX’s Williams % R (14) is -13.33, which suggests PTX is a Sell.

What is PTX’s CCI (14)?

PTX’s CCI (14) is 134.09, which suggests PTX is a Sell.

What is the share price of Prescient Therapeutics Limited?

Prescient Therapeutics Limited's share price is 0.06AU$.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing